2-Methyltryptamine CAS 2731-06-8 Mimo>99.0% (HPLC) Panobinostat Intermediate Factory Didara to gaju

Apejuwe kukuru:

Orukọ Kemikali: 2-Methyltryptamine

CAS: 2731-06-8

Mimọ:> 99.0% (HPLC)

Irisi: Brown ri to

Agbedemeji ti Panobinostat (CAS: 404950-80-7)

Didara to gaju, iṣelọpọ Iṣowo

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Ipese Olupese Pẹlu Didara to gaju, iṣelọpọ Iṣowo
Orukọ Kemikali: 2-Methyltryptamine CAS: 2731-06-8

Kemikali Properties:

Orukọ Kemikali 2-Methyltryptamine
Awọn itumọ ọrọ sisọ 2-Methylindole-3-Ethylamine;2- (2-Methyl-1H-indol-3-yl) etanamine;3- (2-Aminoethyl) -2-Methylindole
Nọmba CAS 2731-06-8
NỌMBA CAT RF-PI1480
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Ilana molikula C11H14N2
Òṣuwọn Molikula 174.25
Ojuami Iyo 106.0 si 110.0 ℃
Ojuami farabale 177℃/1.5mmHg(tan.)
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Brown ri to
Mimọ / Analysis Ọna > 99.0% (Agbegbe HPLC)
1-HNMR Ni ibamu Pẹlu Be
Pipadanu lori Gbigbe <1.00%
Nikan Aimọ <0.50%
Lapapọ Awọn Aimọ <1.00%
Awọn irin Heavy (gẹgẹbi Pb) <20ppm
Igbeyewo Standard Standard Enterprise
Lilo Awọn agbedemeji elegbogi;Panobinostat Intermediate

Package & Ibi ipamọ:

Package: Igo, apo apamọwọ Aluminiomu, 25kg / Paali Drum, tabi gẹgẹbi ibeere alabara.

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin.

Awọn anfani:

1

FAQ:

Ohun elo:

2-Methyltryptamine (CAS: 2731-06-8) jẹ ohun elo ibẹrẹ bọtini kan ninu iṣelọpọ ti Panobinostat (LBH589) (CAS: 404950-80-7).Panobinostat jẹ oludaniloju to lagbara ti gbogbo awọn deacetylases histone (HDACs), pẹlu awọn iye Ki ti o wa lati 0.6 si 31 nM fun HDAC1-11.Nipasẹ iṣe yii, o nyorisi acetylation ti ọpọlọpọ awọn ọlọjẹ cellular, ti o mu ki imuni ọmọ inu sẹẹli ati apoptosis ninu awọn sẹẹli alakan.Panobinostat jẹ onidalẹkun HDAC akọkọ ti a fọwọsi nipasẹ FDA fun itọju ọpọlọpọ myeloma.Panobinostat ti wa ni tita bi Farydak, ti ​​a lo ni apapo pẹlu Bortezomib (CAS: 179324-69-7) ati Dexamethasone (CAS: 50-02-2) lati ṣe itọju ọpọ myeloma ti o tun pada lẹhin itọju iṣaaju pẹlu Bortezomib ati imunomodulator.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa